​

Elanco Animal Health (ELAN) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ELAN Stock Forecast

Elanco Animal Health (ELAN) stock forecast, based on 14 Wall Street analysts, predicts a 12-month average price target of $11.50, with a high of $12.00 and a low of $11.00. This represents a -19.41% decline from the last price of $14.27.

$11 $12 $13 $14 $15 $16 $17 $18 High: $12 Avg: $11.5 Low: $11 Last Closed Price: $14.27

ELAN Stock Rating

Elanco Animal Health stock's rating consensus is Buy, based on 14 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 9 Buy (64.29%), 4 Hold (28.57%), 1 Sell (7.14%), and 0 Strong Sell (0.00%).

Buy
Total 14 0 1 4 9 Strong Sell Sell Hold Buy Strong Buy

ELAN Price Target Upside V Benchmarks

TypeNameUpside
StockElanco Animal Health-19.41%
SectorHealthcare Stocks 24.81%
IndustrySpecialty & Generic Drug Manufacturers Stocks29.65%

Price Target Trends

1M3M12M
# Anlaysts-16
Avg Price Target-$11.00$15.50
Last Closing Price$14.27$14.27$14.27
Upside/Downside--22.92%8.62%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 25168--15
May, 25257--14
Apr, 25267--15
Mar, 25367--16
Feb, 25268--16
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 07, 2025Daniel ClarkLeerink Partners$11.00$9.5115.67%-22.92%
Mar 06, 2025Piper Sandler$12.00$10.8310.80%-15.91%
Dec 09, 2024Andrea AlfonsoUBS$18.00$12.5044.00%26.14%
Dec 02, 2024Daniel ClarkLeerink Partners$14.00$13.166.38%-1.89%
Sep 23, 2024Balaji PrasadBarclays$22.00$14.0756.36%54.17%
Jul 01, 2024David WestenbergPiper Sandler$16.00$14.4310.88%12.12%
May 13, 2024David WestenbergPiper Sandler$19.00$17.0011.76%33.15%
Mar 12, 2024David WestenbergPiper Sandler$18.00$15.7714.14%26.14%
Jan 05, 2024Jonathan BlockStifel Nicolaus$20.00$15.4529.45%40.15%
Sep 12, 2022Barclays$18.00$15.0020.00%26.14%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 21, 2025Cowen & Co.BuyBuyhold
Dec 09, 2024UBSBuyinitialise
Dec 02, 2024Leerink PartnersMarket Performinitialise
Oct 28, 2024Morgan StanleyBuyBuyhold
Sep 23, 2024BarclaysOverweightOverweighthold
Sep 20, 2024Piper SandlerNeutralNeutralhold
Sep 19, 2024Morgan StanleyUnderperformUnderperformhold
Sep 19, 2024Morgan StanleyOverweightEqual-Weightdowngrade
Jul 01, 2024Piper SandlerNeutralNeutralhold
May 13, 2024Piper SandlerNeutralNeutralhold

Financial Forecast

EPS Forecast

$-3 $-2 $-1 $0 $1 $2 $3 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.27$-0.97$-0.15$-2.50$0.68----
Avg Forecast$0.45$1.01$1.04$0.92$0.91$0.90$1.05$1.22$1.44
High Forecast$0.46$1.02$1.06$0.95$0.92$0.99$2.32$1.49$1.47
Low Forecast$0.44$0.99$1.03$0.91$0.90$0.82$0.28$0.86$1.42
Surprise %-382.22%-196.04%-114.42%-371.74%-25.27%----

Revenue Forecast

$3B $4B $4B $5B $5B $6B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$3.27B$4.76B$4.42B$4.42B$4.44B----
Avg Forecast$3.19B$4.75B$4.41B$4.39B$4.42B$4.54B$4.75B$5.03B$5.28B
High Forecast$3.21B$4.79B$4.45B$4.40B$4.44B$4.57B$4.75B$5.04B$5.36B
Low Forecast$3.15B$4.70B$4.38B$4.38B$4.34B$4.49B$4.75B$5.01B$5.23B
Surprise %2.66%0.21%0.19%0.72%0.35%----

Net Income Forecast

$-2B $-1B $-600M $100M $800M $2B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-560.10M$-472.00M$-74.00M$-1.23B$338.00M----
Avg Forecast$-432.65M$-378.78M$-141.47M$-1.23B$450.17M$445.93M$639.60M$578.20M$710.55M
High Forecast$-346.12M$-303.02M$-94.52M$-822.50M$455.07M$487.35M$1.14B$732.39M$722.92M
Low Forecast$-519.18M$-454.53M$-188.41M$-1.64B$445.28M$404.50M$137.76M$424.01M$700.70M
Surprise %29.46%24.61%-47.69%--24.92%----

ELAN Forecast FAQ

Is Elanco Animal Health stock a buy?

Elanco Animal Health stock has a consensus rating of Buy, based on 14 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 9 Buy, 4 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Elanco Animal Health is a favorable investment for most analysts.

What is Elanco Animal Health's price target?

Elanco Animal Health's price target, set by 14 Wall Street analysts, averages $11.5 over the next 12 months. The price target range spans from $11 at the low end to $12 at the high end, suggesting a potential -19.41% change from the previous closing price of $14.27.

How does Elanco Animal Health stock forecast compare to its benchmarks?

Elanco Animal Health's stock forecast shows a -19.41% downside, underperforming the average forecast for the healthcare stocks sector (24.81%) and underperforming the specialty & generic drug manufacturers stocks industry (29.65%).

What is the breakdown of analyst ratings for Elanco Animal Health over the past three months?

  • June 2025: 6.67% Strong Buy, 40.00% Buy, 53.33% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 14.29% Strong Buy, 35.71% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 13.33% Strong Buy, 40.00% Buy, 46.67% Hold, 0% Sell, 0% Strong Sell.

What is Elanco Animal Health’s EPS forecast?

Elanco Animal Health's average annual EPS forecast for its fiscal year ending in December 2025 is $0.9, marking a 32.35% increase from the reported $0.68 in 2024. Estimates for the following years are $1.05 in 2026, $1.22 in 2027, and $1.44 in 2028.

What is Elanco Animal Health’s revenue forecast?

Elanco Animal Health's average annual revenue forecast for its fiscal year ending in December 2025 is $4.54B, reflecting a 2.31% increase from the reported $4.44B in 2024. The forecast for 2026 is $4.75B, followed by $5.03B for 2027, and $5.28B for 2028.

What is Elanco Animal Health’s net income forecast?

Elanco Animal Health's net income forecast for the fiscal year ending in December 2025 stands at $445.93M, representing an 31.93% increase from the reported $338M in 2024. Projections indicate $639.6M in 2026, $578.2M in 2027, and $710.55M in 2028.